After identifying NOS as a mechanism that M-MDSCs utilize to suppress CD8 proliferation in the ex vivo assay, we then sought to determine if iNOS is expressed by glioma-associated M-MDSCs in vivo. The gene discussed is NOS2; the disease is central nervous system cancer.